Stay updated on Pembrolizumab Combo in Ovary Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Ovary Cancer Clinical Trial page
- Check6 days agoChange DetectedAdded recruitment status text and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a page revision indicator (Revision: v3.6.0). Standardized the Intervention/Treatment heading by replacing 'Intervention / Treatment' and removed the older 'Revision: v3.5.5' tag.SummaryDifference0.4%

- Check13 days agoChange DetectedAdded related topics including Ovarian cancer and MedlinePlus Genetics, and updated the site revision from v3.5.4 to v3.5.5.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA full bibliographic citation for an older study was added to the Publications section, and the revision tag Revision: v3.5.4 was included. The erratum note associated with that citation was removed from the Publications/related topics list.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page's related topics metadata was updated to include 'Ovarian cancer' and 'MedlinePlus Genetics'. This change broadens how the study is indexed for ovarian cancer-related searches without altering the study content.SummaryDifference0.1%

- Check56 days agoChange DetectedA revision/version label on the page was updated from the prior release, indicating a minor ClinicalTrials.gov site change. Additionally, some “related topics” entries in the auxiliary information area (e.g., MedlinePlus Genetics) were removed, without affecting the study details.SummaryDifference0.2%

- Check63 days agoChange Detected- Updated bibliographic reference: revision changed from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Ovary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.